JPS50137987A - - Google Patents

Info

Publication number
JPS50137987A
JPS50137987A JP4596174A JP4596174A JPS50137987A JP S50137987 A JPS50137987 A JP S50137987A JP 4596174 A JP4596174 A JP 4596174A JP 4596174 A JP4596174 A JP 4596174A JP S50137987 A JPS50137987 A JP S50137987A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4596174A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP4596174A priority Critical patent/JPS50137987A/ja
Publication of JPS50137987A publication Critical patent/JPS50137987A/ja
Pending legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP4596174A 1974-04-25 1974-04-25 Pending JPS50137987A (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4596174A JPS50137987A (ru) 1974-04-25 1974-04-25

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4596174A JPS50137987A (ru) 1974-04-25 1974-04-25

Publications (1)

Publication Number Publication Date
JPS50137987A true JPS50137987A (ru) 1975-11-01

Family

ID=12733837

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4596174A Pending JPS50137987A (ru) 1974-04-25 1974-04-25

Country Status (1)

Country Link
JP (1) JPS50137987A (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150005295A1 (en) * 2012-01-06 2015-01-01 Janssen R&D Ireland 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150005295A1 (en) * 2012-01-06 2015-01-01 Janssen R&D Ireland 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b
JP2015508402A (ja) * 2012-01-06 2015-03-19 ヤンセン サイエンシズ アイルランド ユーシー 4,4−二置換−1,4−ジヒドロピリミジン、及びb型肝炎の処置のための医薬としてのその使用
US9233933B2 (en) * 2012-01-06 2016-01-12 Janssen Sciences Ireland Uc 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis B

Similar Documents

Publication Publication Date Title
FR2273246B1 (ru)
BR7501650A (ru)
FR2291032B1 (ru)
FI222874A (ru)
JPS50127092A (ru)
JPS50119742A (ru)
FR2272041B1 (ru)
FR2273071B1 (ru)
JPS50103275A (ru)
JPS50137987A (ru)
JPS50114014A (ru)
JPS50129317U (ru)
JPS50140193A (ru)
AU7474774A (ru)
JPS50106662U (ru)
JPS50113709U (ru)
JPS50123051U (ru)
JPS50130355U (ru)
BG20739A1 (ru)
CH1131875A4 (ru)
BG20947A1 (ru)
BG21393A3 (ru)
CH566447A5 (ru)
BG22007A1 (ru)
BG22209A1 (ru)